Key Decision and Effective Date
The Board of Directors of Bharat Parenterals Limited, at its meeting held on August 05, 2026, approved the re-appointment of Mr. Hemang Shah (DIN: 03024324) as an Executive Director of the Company. The re-appointment is for a term of 5 (five) consecutive years, effective from July 02, 2026, up to July 01, 2031.
Conditions and Approvals
The re-appointment is based on the recommendation of the Nomination and Remuneration Committee and the Audit Committee. It is subject to the approval of shareholders at the ensuing Annual General Meeting.
Compliance Verification
The Nomination and Remuneration Committee and the Board verified that Mr. Hemang Shah is not debarred from holding the office of Director pursuant to any order of the Ministry of Corporate Affairs (MCA), SEBI, or any other authorities.
Annexure Details (Annexure A)
The disclosure includes annexure details as required by Regulation 30 read with Schedule III of SEBI LODR and SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026:
- Name: Hemang Jayendrabhai Shah
- Reason for Change: Re-appointment as an Executive Director.
- Date & Term of Re-appointment: July 02, 2026, for a term ending July 01, 2031.
- Brief Profile: Mr. Hemang Shah is a Bachelor of Commerce and also holds a degree of MSW (Master of Social Work). He has been associated with the Company for more than the last two decades and has played a pivotal role in its growth and development. He has more than 30 years of rich experience.
- Relationship Disclosure: Mr. Hemang Shah is not related to any other Director of the Company.
Additional Information
The above information is also available on the Company's website at www.bplindia.in.